The Patent Finder

Terms ending in 2028

Genentech, Inc.

Every in-force patent on Genentech, Inc.'s record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 11,008,401Multispecific Antibodies
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 7,892,544Humanized Anti-Beta-Amyloid Antibody
In force
 · High confidence
Ac Immune S.A.In forceHigh confidence
US 8,853,199Hydroxylated and Methoxylated Pyrimidyl Cyclopentanes as Akt Protein Kinase Inhibitors
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 7,915,390ANTI-NOTCH3 Agonist Antibodies and Their Use in the Treatment of NOTCH3-RELATED Diseases
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 7,888,352Phosphoinositide 3-Kinase Inhibitor Compounds and Methods of Use
In force
 · High confidence
F. Hoffmann-La Roche AGIn forceHigh confidence
US 9,970,043Process for Producing Optically Active 2-Alkyl-1,1,3-Trialkoxycarbonylpropane
In force
 · Medium confidence
Genentech, Inc.In forceMedium confidence
US 10,385,405Gene Expression Markers of Tumor Resistance to HER2 Inhibitor Treatment
In force
 · Medium confidence
Genentech, Inc.In forceMedium confidence
US 9,585,956Polynucleotides Encoding Anti-Amyloid Beta Monoclonal Antibodies
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 8,846,683Pyrimidyl Cyclopentanes as Akt Protein Kinase Inhibitors
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 9,409,886Pyrimidyl Cyclopentanes as Akt Protein Kinase Inhibitors
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
31 more term ends in 2028 · Pro
10 of 41 patents shown. Soonest term end first, then patent number.
Pro members see all 41, including 6 expiring within the 18 months from Nov 17, 2026.
Upgrade to Pro
35 of these are in force and held by Genentech, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited